Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-02-14

Clinical Trial Update: European Clinical Evaluation of the Carmat Total Artificial Heart [NA]

View source ↗

Summary

European clinical evaluation of the Carmat Total Artificial Heart has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carmat Total Artificial Heart

Snippet

Sponsor: Carmat SAS | Conditions: Advanced Heart Failure | NA | Status: SUSPENDED